Menu
Home
About
Management Team
Board of Directors
Scientific Advisory Team
Technology
PP-001
CMHA-S Platform
Pipeline
Investors
Corporate Presentation
Stock Information
SEC Filings
Analyst Info
Corporate Governance
IR Contact
News
Contact
Home
>
IR
IR
Stock Quote
EYEG (Common Stock)
Exchange
NASDAQ
Price
$1.95
Change
0.00
Volume
768
Data as of
Oct 18, 2021 4:00PM
Press Releases
September 9, 2021
EyeGate to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 8, 2021
EyeGate Pharma Completes Target Enrollment in Phase 2 Proof-of-Concept Study to Evaluate PP-001 for the Treatment of Ocular Surface Inflammation
August 12, 2021
EyeGate Pharma Reports Second Quarter 2021 Financial Results and Provides Business Update
August 10, 2021
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
July 26, 2021
EyeGate Pharmaceuticals Announces Appointment of Brian M. Strem, Ph.D., as President and Chief Executive Officer
